AstraZeneca makes $275 million in sales from COVID vaccine
Austria courts face fallout from ski resorts’ virus spread
30 April 2021New genetic target for blood cancer treatment
30 April 2021AstraZeneca makes $275 million in sales from COVID vaccine
British pharmaceuticals giant AstraZeneca reported on Friday $275 million (227 million euros) in sales from its COVID vaccine in the first three months of the year.
